Our Summary

This study looked at the rate of recurrence of a type of ovarian cyst, known as endometrioma, in women who underwent a specific surgical treatment called unilateral salpingo-oophorectomy (USO). The study included 110 women aged 35-45 who had either a USO or a cystectomy, another type of surgery, to treat a single ovarian endometrioma between 2010 and 2012.

The researchers found that in women who had USO, endometrioma recurred in 16% of patients, with a higher rate of recurrence in the first five years after surgery. They also found that women who had adhesions (scar tissue) on the opposite side of their body were more likely to have a recurrence of endometrioma after USO.

This is the first study to report on the rate of recurrence and risk factors for recurrence after USO. The findings could help in planning USO and in deciding which patients should receive hormonal therapy after surgery.

FAQs

  1. What is the rate of recurrence for endometrioma in women who underwent unilateral salpingo-oophorectomy (USO)?
  2. What factors were found to increase the likelihood of endometrioma recurrence after USO?
  3. How could the findings of this study potentially impact treatment plans and decisions about hormonal therapy after USO?

Doctor’s Tip

One helpful tip a doctor might tell a patient about salpingo-oophorectomy is to discuss the risk of recurrence of ovarian cysts, such as endometrioma, after the surgery. It is important to be aware that there is a possibility of recurrence, especially in the first five years after surgery. Patients should also be informed that having adhesions on the opposite side of their body may increase the risk of recurrence. This information can help in determining the appropriate postoperative care and follow-up plan to prevent or manage any potential recurrences.

Suitable For

Patients who are typically recommended for salpingo-oophorectomy include:

  1. Women with ovarian cysts, particularly endometriomas, that are causing symptoms such as pain or discomfort.
  2. Women with a family history of ovarian cancer or a genetic predisposition to ovarian cancer, such as carrying a BRCA1 or BRCA2 gene mutation.
  3. Women with a history of pelvic inflammatory disease or other gynecological conditions that increase the risk of developing ovarian cysts.
  4. Women with a history of endometriosis that has not responded to other treatments.
  5. Women with a history of recurrent ovarian cysts that have not responded to other treatments.
  6. Women who are postmenopausal and have been diagnosed with ovarian cysts that are at risk of being cancerous.
  7. Women who have previously undergone fertility treatments and have persistent ovarian cysts that are affecting their ability to conceive.

Timeline

Before salpingo-oophorectomy:

  • Patient experiences symptoms such as pelvic pain, bloating, and abnormal bleeding
  • Patient undergoes diagnostic tests such as ultrasound or MRI to confirm the presence of ovarian cysts
  • Patient discusses treatment options with their healthcare provider, including the possibility of salpingo-oophorectomy
  • Patient undergoes pre-operative testing and preparation for surgery

After salpingo-oophorectomy:

  • Patient undergoes the surgical procedure, which involves removing one or both ovaries and fallopian tubes
  • Patient stays in the hospital for a period of time for recovery
  • Patient experiences post-operative pain and discomfort, which is managed with pain medications
  • Patient may experience temporary hormonal changes and menopausal symptoms, which can be managed with hormone replacement therapy
  • Patient follows up with their healthcare provider for monitoring and to address any complications or concerns
  • Patient may undergo further treatment or monitoring for recurrence of ovarian cysts, as seen in the study mentioned above.

What to Ask Your Doctor

  1. What is a salpingo-oophorectomy and why is it being recommended for me?
  2. What are the potential risks and complications associated with a salpingo-oophorectomy?
  3. How will a salpingo-oophorectomy affect my fertility and menopausal symptoms?
  4. Are there any alternative treatment options to a salpingo-oophorectomy that I should consider?
  5. What is the expected recovery time and post-operative care for a salpingo-oophorectomy?
  6. How often will I need follow-up appointments after the surgery?
  7. What are the chances of the ovarian cyst recurring after a salpingo-oophorectomy?
  8. Are there any lifestyle changes or medications that can help reduce the risk of recurrence?
  9. How will a salpingo-oophorectomy affect my overall health and well-being in the long term?
  10. Are there any specific risk factors or characteristics in my case that may impact the success of a salpingo-oophorectomy?

Reference

Authors: Hidari T, Hirata T, Arakawa T, Koga K, Neriishi K, Fukuda S, Nakazawa A, Nagashima N, Ma S, Sun H, Takamura M, Harada M, Hirota Y, Wada-Hiraike O, Fujii T, Osuga Y. Journal: BMC Womens Health. 2019 May 2;19(1):59. doi: 10.1186/s12905-019-0760-z. PMID: 31046768